Paydirt
Insider filing · ANVS

Michael B Hoffman bought $5.0M of Annovis Bio (ANVS)

Executed Nov 6, disclosed Nov 6, the same day.

Value, as filed
$5.0M
5,000,000 sh × $1.00
Executed
Nov 6
the trade date, as filed
Disclosed
Nov 6
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer
MH Michael B Hoffman Director profile →

Michael B Hoffman (Director) filed 7 Form 4 reports in the trailing twelve months (7 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in Annovis Bio, Inc. (ANVS). Across 5 priced purchase filings, the average 21-session return was +21.1% from execution and +6.9% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of ANVS (5,000,000 sh × $1.00, as filed), executed Nov 6.

The name
ANVS Annovis Bio, Inc. ANVS · Healthcare · 8 filings in 24 months ticker →

Healthcare · Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Michael B Hoffman in ANVS
ANVSPURCHASE Annovis Bio, Inc. $104K
54,933 sh × $1.90
Exec May 20
Filed May 21 · 8:11 PM ET ANVSPURCHASE Annovis Bio, Inc. $1.5M
713,800 sh × $2.10
Exec Apr 2
Filed Apr 3 · 5:06 PM ET ANVSPURCHASE Annovis Bio, Inc. $130K
30,000 sh × $4.34
Exec Dec 8 2025
Filed Dec 8 2025 · 8:05 PM ET ANVSPURCHASE Annovis Bio, Inc. $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 6:59 PM ET ANVSPURCHASE Annovis Bio, Inc. $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 12:26 PM ET ANVSPURCHASE Annovis Bio, Inc. $2.0M
975,610 sh × $2.05
Exec Oct 28 2025
Filed Nov 12 2025 · 9:18 AM ET †